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EVAR because of anatomic considerations. We sought to
examine the applicability of EVAR in current practice and
to identify the anatomic barriers to widespread use of the
procedure that should guide future device development.
METHODS
All patients who came to our institution for infrarenal
AAA repair between April 1998 and June 2000 were
offered evaluation for EVAR. Thin-cut (3 mm) spiral com-
puted tomography (CT) scans and calibrated catheter arte-
riograms were obtained on all patients, and their anatomic
characteristics were prospectively entered into a database.
Patients were identified as “high risk” on the basis of
cardiopulmonary risk factors, including unstable angina,
significant areas of myocardium at risk on the basis of coro-
nary angiography or radionuclide scans, a left ventricular
ejection fraction less than 20%, recent congestive heart fail-
ure, chronic obstructive pulmonary disease requiring home
oxygen, or a forced expirator flow rate less than 20% of that
predicted.
Anatomic exclusion criteria used as a means of reject-
ing patients for EVAR are shown in Table I. A wide selec-
Wide-ranging predictions have been made about the
general applicability of endovascular repair of abdominal
aortic aneurysms (EVAR).1,2 Recent reports of individual
device trials have indicated that 20% to 54% of patients with
an abdominal aortic aneurysm (AAA) can be treated with
the devices currently used.3,4 Availability of US Food and
Drug Administration–approved devices has removed the
restrictions on patient selection, which had been controlled
by device trials. Although the precise indications for EVAR
are still unclear, many patients for whom the procedure
could potentially be of benefit are unable to qualify for
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Purpose: Wide-ranging predictions have been made about the usefulness of endovascular repair for patients with abdom-
inal aortic aneurysms (AAAs). The availability of US Food and Drug Administration–approved devices has removed
the restrictions on patient selection, which had been controlled by device trials. This study examined the applicability
of endovascular AAA repair and identified the anatomic barriers to successful endovascular AAA repair that should
guide future device development.
Methods: All patients who came to our institution for infrarenal AAA repair between April 1998 and June 2000 were
offered evaluation for endovascular repair. Thin-cut spiral computed tomography scans and arteriograms were obtained
on all patients, and their anatomic characteristics were prospectively entered into a database. A wide selection of avail-
able devices allowed the treatment of diverse AAA anatomic features.
Results: A total of 307 patients were examined (264 men, 43 women). Of these, 204 patients (66%; 185 men, 19 women)
underwent endovascular repair, and 103 patients (34%, 79 men, 24 women) were rejected. Reasons for exclusion
included short aneurysm neck (56, 54%), inadequate access because of small iliac arteries (48, 47%), wide aneurysm neck
(41, 40%), presence of bilateral common iliac aneurysms extending to the hypogastric artery (22, 21%), excessive neck
angulation (14, 14%), extensive mural thrombus in the aneurysm neck (10, 10%), extreme tortuosity of the iliac arter-
ies (10, 10%), accessory renal arteries originating from the AAA (6, 6%), malignancy discovered during the examination
(5, 5%), and death during the examination interval (2, 2%). Rejected patients had an average of 1.9 exclusion criteria
(range, 1 to 4). A disproportionate number of women were excluded because of anatomic findings (P = .0009).
Although 80% of patients who were at low risk for surgery qualified for endovascular repair, only 49% of our patients
who were at high risk for surgery were acceptable candidates (P < .001). Of the 103 patients who were excluded, 34
(33%) underwent open surgical repair, and the remaining 69 (67%) were deemed to be unfit for open surgery. Three
patients (1.4%) failed endograft placement because of inadequate vascular access.
Conclusion: Most infrarenal AAAs (66%) can be treated with endovascular devices currently available commercially or
through US Food and Drug Administration–approved clinical trials. However, patients who are at high risk for surgery
and might benefit most from endovascular repair are less likely to qualify for the procedure (49%). Men (70%) are more
likely than women (40%) to meet the anatomic criteria for endografting. Difficulties with vascular access and attachment
site geometry predominate as reasons for exclusion. Our findings suggest that smaller profile devices, which can negoti-
ate small and tortuous iliac arteries, are needed. Proximal and distal attachment site problems require devices that can
accommodate wide and angulated attachment necks and achieve short seal zones. (J Vasc Surg 2001;34:1050-4.)
tion of devices, both bifurcated and aortomonoiliac,
allowed the treatment of patients with an AAA who had
diverse anatomic features (Table II).
Devices were implanted with standard endovascular
techniques, according to the manufacturers’ implantation
protocols, by using unilateral or bilateral femoral artery
exposures. The Cordis device was implanted percutaneously
via bilateral femoral artery punctures. Intraoperative
roadmap arteriography was used as a means of ensuring
proper device deployment, and post-procedure intraopera-
tive arteriography was used as a means of determining the
adequacy of the endovascular repair. Coil embolization of
patent hypogastric arteries that were to be covered by endo-
grafts was performed before endograft placement as a sepa-
rate procedure. Aortomonoiliac devices necessitated the
JOURNAL OF VASCULAR SURGERY
Volume 34, Number 6 Carpenter et al 1051
placement of femorofemoral bypass grafts, which were con-
structed of externally supported polytetrafluoroethylene (8
mm or 10 mm). These grafts were sewn to the site of the
femoral arteriotomy used for device delivery.
RESULTS
A total of 307 patients were examined (264 men, 43
women). Patients were categorized as high risk (unable
to tolerate conventional open AAA surgery, N = 136) or
low risk (acceptable for conventional open AAA surgery,
N = 171). Of these 307 patients, 204 (66%; 185 men, 19
women) underwent endovascular repair, and 103 (34%;
79 men, 24 women) were rejected. Reasons for rejection
were chiefly anatomic characteristics of the aortic neck or
access arteries (Fig 1). The patients who were rejected
Fig 1. Fate of 307 patients with an AAA who were candidates for EVAR. Of those accepted for EVAR (66%), the procedure was per-
formed successfully in all patients except three. A total of 93% of rejections were made on the basis of anatomic unsuitability for avail-
able devices.
Fig 2. Sex bias in EVAR candidate selection. Rejection of female patients was disproportionately higher than that of male patients (P <
.001). Neck issues were the predominant factor accounting for this observation.
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had an average of 1.9 exclusion criteria (range, 1-4). The
ratio of men to women who were candidates for EVAR
was six to one. Although 70% of male candidates quali-
fied for EVAR, only 44% of female candidates were
accepted (P < .001). Thus, a disproportionate number of
women were excluded because of anatomic findings (Fig
2). Neck issues predominated as the reason for rejection
of female patients, and access issues were the second
most frequent reason for rejection. Endograft placement
failed in three patients (1.4%) because of inadequate vas-
cular access.
Patients in the high-risk group were less likely to be
accepted for EVAR than patients in the low-risk group
(49% vs 80%, P < .001; Table III). Of the patients under-
going EVAR, 65 (31%) were in the high-risk group. Of
the patients excluded from consideration for EVAR, 69
(67%) were in the high-risk cohort and were treated med-
ically for their AAA (Fig 3). The population excluded from
EVAR had a significantly higher proportion of patients in
the high-risk group than the group of patients accepted
for EVAR (67% vs 33%, P < .001). Reasons for rejection,
stratified by risk group, are shown in Table IV.
DISCUSSION
The indications for EVAR are as yet unclear. Recent
reports of aneurysm rupture despite seemingly successful
EVAR clearly indicate that further refinement of the tech-
nology is needed.5-8 Although it is still in its infancy, EVAR
is being offered to a large number of patients and is expected
to increase in its applicability as the technology is improved.
We found that we were able to offer EVAR to 66% of
our patients with an AAA when anatomic criteria alone
were considered, using a large variety of EVAR devices
available to us via clinical trials. Other authors have reported
that 45% to 80% of patients with an AAA are candidates for
Fig 3. Fate of patients rejected for EVAR. Most patients undergoing EVAR (69%) also qualified as candidates for conventional open
surgery. Patients excluded from EVAR were most often also found to be unfit for conventional open AAA surgery. Patient candidates
who were at high risk were more likely than patients at low risk to be excluded from EVAR (51% vs 20%, P < .001).
Table I. Exclusion criteria for endovascular repair of
abdominal aortic aneurysms
Aortic neck diameter >28 mm
Aortic neck length <15 mm
Aortic neck angulation >60°
Severe iliac tortuosity
Extensive aortic neck thrombus
Access artery diameter (iliacs) <7 mm
Aortic bifurcation diameter <18 mm
Bilateral common iliac aneurysm requiring coverage of both 
hypogastric arteries
Essential accessory renal artery
Table II. Devices, configurations, and dates of availability
for endovascular repair of abdominal aortic aneurysms
(204 endografts)
Device N Availability
Talent 120 Entire study interval
Ancure 36 Entire study interval
AneuRx 35 Entire study interval
Zenith 5 February 2000 to study
end
Lifepath 4 February to May 2000
Cordis 4 January to April 2000
Aortomonoiliac, 33; bifurcated, 171.
Table III. Results of candidacy for endovascular repair
of abdominal aortic aneurysms by risk group
Accepted for Rejected for
Risk group endovascular repair endovascular repair
High 67 69
Low 137 34
Patients in the high-risk group were less likely to be accepted for endovas-
cular repair than patients in the low-risk group (49% vs 80%, P < .001).
EVAR when anatomic criteria are applied.1-3,9-11 When only
a single device is available, however, the rate may be as low
as 20%, indicating the value of having a selection of devices
and configurations available to offer patients.4 No single
device can be universally used for all EVAR procedures.
Neck issues predominated as the reason for exclusion
from EVAR candidacy. Other authors1-4 also have identi-
fied this as the chief anatomic barrier to widespread applic-
ability with currently available devices. Short necks,
offering small proximal attachment lengths and seal zones,
are thought to place patients at high risk for attachment
site leaks. The short-length neck is often seen in combina-
tion with a wide neck diameter,1 particularly in AAAs
larger than 7 cm. Transrenal fixation may facilitate our
ability to treat these patients, allowing for attachment in
the more stable suprarenal aortic segment. This strategy
also may be applicable to patients with thrombus-filled
aortic necks, which place patients at risk for device migra-
tion and poor sealing.9
Access issues were another common cause of exclusion
from EVAR. Although the use of conduits to the common
iliac arteries allows one to bypass the smaller external iliac
vessels, this approach diminishes the minimally invasive
benefits of EVAR. Smaller profile, more tapered and flex-
ible delivery systems are clearly needed, with percutaneous
placement of durable devices the eventually desired goal.
The presence of bilateral common iliac aneurysms was
found in 21% of our patients. The risk of colonic ischemia
and claudication precludes routine coverage of both
hypogastric arteries, which is necessary for patients with
bilateral common iliac artery aneurysms. This has been
noted as a common exclusion criterion by a number of
other authors.1,4,10 Some have performed EVAR with dis-
tal attachment sites in the external iliac arteries covering
both hypogastric arteries, combined with surgical revascu-
larization of the hypogastric arteries.12 This operation is
admittedly difficult and increases the invasiveness of the
overall AAA repair approach. The use of “bell bottom”
iliac endolimbs or devices that use fenestrations or limb
side branches may ultimately allow successful EVAR in
these patients, without the need for adjunctive surgical
revascularization of the hypogastric arteries.
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Neck angulation results in poor proximal attachment
and kinking. The use of newer devices with “steerable”
proximal ends and the development of flexible but kink
resistance materials and designs that follow the contour of
the AAA neck are hoped to reduce the importance of this
anatomic exclusion criterion.
Small and calcified aortic bifurcations do not accom-
modate the presence of two bifurcated graft limbs, leading
to kinking, limb failure, and difficulty with device place-
ment.13 Narrow aortic bifurcations are thus best treated
with aortomonoiliac devices. Access to an aortomonoiliac
device is an important complement to bifurcated devices
in the treatment of AAA with EVAR. We were able to
increase the number of patients who we can treat with
EVAR by 19% by using aortomonoiliac grafts. Other
authors have reported that access to both bifurcated and
aortomonoiliac designs may increase the number of
patients in whom EVAR may be applied1,10 by as much as
50%. These grafts are also useful in the situation of unilat-
eral iliac occlusive disease, which precludes the use of a
bifurcated design. The placement of aortomonoiliac grafts
necessitates the placement of a femorofemoral bypass graft
also. Patency of these bypass grafts in the setting of
aneurysm (rather than occlusive) disease has reportedly
been excellent, and their chief drawback has been the risk
of graft infection.13
Sex issues are important in the selection of patients for
EVAR. The smaller size of women compared with men
explains our finding of more frequent rejection of women
on the basis of small access arteries. The most common
reason for rejection of female candidates, however, was
related to neck geometry, which we found to be problem-
atic in a higher proportion of women than men.14
We have found CT angiography (CTA) and arteriog-
raphy to be complementary techniques for providing reli-
able size and length measurements, leading to technically
successful EVAR in 98.6% of our patients in whom the
procedure was attempted. CTA alone15 may provide a
comparable result with less cost and patient morbidity. For
patients with renal insufficiency, we have favored the use
of magnetic resonance angiography for both diameter and
length measurements.16,17 This approach has been found
Table IV. Comparison of reasons for exclusion according to risk group
Criterion High-risk group Low-risk group P value (P)
Short neck (mean length) 38 (3 mm) 18 (2.2 mm) .84 (.32)
Small iliacs (mean diameter) 35 (5.4 mm) 13 (5.4 mm) .23 (.64)
Wide neck (mean diameter) 30 (34 mm) 11 (33 mm) .28 (.73)
Bilateral common iliac aneurysms 14 8 .71
Neck angulation 8 6 .40
Neck thrombus 8 2 .36
Iliac tortuosity 8 2 .36
Accessory renal artery 1 5 .01
Narrow aortic bifurcation 0 2 .04
AAA diameter (mm) 62 59 .36
Age (y) 76 75 .09
AAA, Abdominal aortic aneurysm.
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to be accurate when compared with CTA and digital sub-
traction angiography.18
Our patients who were rejected for EVAR were found
to present a prohibitive risk for conventional open AAA
repair in 67% of cases. Patients being referred for the pro-
cedure and excluded from EVAR are often “sicker” than
the general population with AAAs. Conversely, and
provocatively, Woodburn et al11 noted that most patients
who are anatomically suitable for EVAR also prove to be
medically acceptable for conventional surgery. Similarly,
we noted that 69% of our patients undergoing EVAR also
qualified as candidates for conventional open surgery.
The population who would be expected to derive the
greatest benefit from the availability of EVAR is the pop-
ulation with AAAs who are at high risk, for whom open
surgical repair is not an option. Fully 80% of our patients
in the low-risk group qualified for EVAR. However,
patients in the high-risk group were rejected for EVAR at
a rate significantly higher than that of their counterparts in
the low-risk group, and they were unable to qualify for
EVAR in most cases (51%).
CONCLUSION
Most infrarenal AAAs (66%) can be treated with
endovascular devices currently available commercially or in
the setting of US Food and Drug Administration–
approved clinical trials. However, patients who are at high
risk, and thus might benefit most from EVAR, are less
likely to qualify for the procedure (49%). Men (70%) are
more likely than women (40%) to meet the anatomic cri-
teria for EVAR. Difficulties with vascular access and
attachment site geometry predominate as reasons for
exclusion. Our findings suggest that smaller profile
devices, which can negotiate small and tortuous iliac arter-
ies, are needed. Proximal and distal attachment site prob-
lems require devices that can accommodate wide and
angulated aortic necks and achieve short seal zones.
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